" class="no-js "lang="en-US"> Antiverse Archives - Medtech Alert
Saturday, September 30, 2023

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification with AI-driven Drug Discovery Platform

Antiverse Ltd, a biotechnology company developing a computational antibody drug discovery platform, has announced the […]

Antiverse Collaborates with a Top 20 Pharma Company to Identify Antibody Drug Candidates Using AI Augmented Drug Discovery Platform

Antiverse, a biotechnology company developing a computational antibody drug discovery platform, today announced a partnership […]

Welsh Startup Antiverse Raises $2m for Antibody Discovery Toolkit

New biotech Antiverse has raised seed funding of £1.4 million ($2 million) to develop its […]

Antiverse Raises £1.4 Million ($2 Million USD) to Advance Its AI Antibody Drug Discovery Platform

Antiverse, a biotechnology company developing a computational antibody drug discovery platform, has raised seed funding […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more